Replies to post #479519 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

I think the NYAS numbers were 13.5% at 5 years for the P3 and 5.8% (k-m) for TTF. These may be slightly off because I am quoting from memory.

[jon_k84]

If you want more information on TTF, read the 2017 Stupp study from JAMA. It did well. Nothing wrong with TTF, but no one knows how many DCVax patients in the study had tried TTF. I'm assuming not many of them otherwise the comparisons wouldn't make any sense.